Announcements Trials

Browse Landscape

Phase

Status

Completed 68 Unknown 19 Recruiting 15 Withdrawn 4 Not yet recruiting 4 Terminated 3 Suspended 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 46 Breast Neoplasms 46 Colorectal Neoplasms 27 Prostatic Neoplasms 26 Carcinoma, Non-Small-Cell Lung 21 Leukemia, Myeloid, Acute 20 Glioblastoma 19 Melanoma 17 Lung Neoplasms 17 Pancreatic Neoplasms 16 Neoplasm Metastasis 16 Glioma 14 Stomach Neoplasms 13 Ovarian Neoplasms 13 Brain Neoplasms 13 Carcinoma, Hepatocellular 12 Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Myelodysplastic Syndromes 11 Triple Negative Breast Neoplasms 10 Multiple Myeloma 10 Head and Neck Neoplasms 10 Carcinoma, Renal Cell 10 Lymphoma 9 Uterine Cervical Neoplasms 7 Sarcoma 7 Rectal Neoplasms 7 Leukemia 7 Hematologic Neoplasms 7 Esophageal Neoplasms 7 Colonic Neoplasms 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × Warts × Clear all

NCT01796795 2023-09-14

Efficacy and Safety of SR-T100 Gel in Common Warts (CW) Patients

G&E Herbal Biotechnology Co., LTD

Phase 2 Suspended

Warts

Data powered by HemOnc (CC BY 4.0) Colophon ⚡